HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,447,092 | +14.1% | 90,238 | +7.8% | 0.03% | +21.7% |
| Q2 2023 | $3,020,430 | -5.6% | 83,738 | 0.0% | 0.02% | -4.2% |
| Q1 2023 | $3,197,954 | +215.3% | 83,738 | +369.8% | 0.02% | +200.0% |
| Q4 2022 | $1,014,299 | +71.0% | 17,826 | +18.8% | 0.01% | +60.0% |
| Q3 2022 | $593,000 | -10.2% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $660,000 | +228.4% | 15,000 | +200.0% | 0.01% | +400.0% |
| Q4 2021 | $201,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |